Momelotinib Found Superior to Danazol for the Treatment of Myelofibrosis
Clinically significant improvements in myelofibrosis-associated symptoms, anemia, and spleen response were achieved with momelotinib, compared with danazol, in patients with myelofibrosis. These findings were published in The Lancet.
Danazol has often been used to treat patients with myelofibrosis,
Clinically significant improvements in myelofibrosis-associated symptoms, anemia, and spleen response were achieved with momelotinib, compared with danazol, in patients with myelofibrosis. These findings were published in The Lancet.
Danazol has often been used to treat patients with myelofibrosis,